Association of Body Composition with Outcome of Docetaxel Chemotherapy in Metastatic Prostate Cancer: A Retrospective Review

BACKGROUND: Docetaxel, a lipophilic drug, is indicated for castration-resistant metastatic prostate cancer. Most men with such disease would have had androgen-deprivation therapy, which decreases muscle and increases body fat. Obesity and body composition changes may influence the outcomes of doceta...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Weixin, Liu, Xiandong, Chaftari, Patrick, Cruz Carreras, Maria Teresa, Gonzalez, Carmen, Viets-Upchurch, Jayne, Merriman, Kelly, Tu, Shi-Ming, Dalal, Shalini, Yeung, Sai-Ching J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379069/
https://www.ncbi.nlm.nih.gov/pubmed/25822612
http://dx.doi.org/10.1371/journal.pone.0122047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379069/
https://www.ncbi.nlm.nih.gov/pubmed/25822612
http://dx.doi.org/10.1371/journal.pone.0122047

Ejemplares similares